Sugi Predict

Sugi Predict / Compounds / SCHEMBL21798669

SCHEMBL21798669

SCHEMBL21798669

COc1cccc(/C=C/C=C/C=C/c2cccc(OC)c2OC)c1OC

nearest known ligand 0.66

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ NFE2L2 Q16236 8/20 0.66
▸ CYP1A1 P04798 4/20 0.65
▸ CYP1A2 P05177 4/20 0.65
▸ CYP1B1 Q16678 3/20 0.65
▸ PRMT1 Q99873 1/20 0.60
▸ CYP19A1 P11511 1/20 0.60
▸ KDM4E B2RXH2 1/20 0.58
▸ MAPT P10636 1/20 0.58
▸ HSD17B10 Q99714 1/20 0.58
▸ CYP2D6 P10635 1/20 0.51
▸ ALOX5 P09917 1/20 0.51
▸ TRPM8 Q7Z2W7 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4393529 0.91 NFE2L2 (0.59) NFE2L2CYP1A1CYP1A2CYP1B1PRMT1
SCHEMBL118591 0.90 NFE2L2 (0.79) NFE2L2CYP1A1CYP1A2CYP1B1PRMT1
SCHEMBL615385 0.88 NFE2L2 (0.77) NFE2L2CYP1A1CYP1A2CYP1B1PRMT1
SCHEMBL8494360 0.87 NFE2L2 (0.63) NFE2L2CYP1A1CYP1A2CYP1B1PRMT1
SCHEMBL2119793 0.87 NFE2L2 (0.63) NFE2L2CYP1A1CYP1A2CYP1B1PRMT1
SCHEMBL27702145 0.87 NFE2L2 (0.60) NFE2L2CYP1A1CYP1A2CYP1B1PRMT1
SCHEMBL14518616 0.84 NFE2L2 (0.66) NFE2L2CYP1A1CYP1A2CYP1B1PRMT1
SCHEMBL7870072 0.84 NFE2L2 (0.66) NFE2L2CYP1A1CYP1A2CYP1B1PRMT1
SCHEMBL5182341 0.82 NFE2L2 (0.69) NFE2L2CYP1A1CYP1A2CYP1B1PRMT1
SCHEMBL1045608 0.82 NFE2L2 (0.64) NFE2L2CYP1A1CYP1A2CYP1B1PRMT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11166891-B2 Bis phenyl hexa trien derivatives, preparation method thereof, and composition for skin whitening containing the same as an active ingredient KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2021-11-09 — — US disclosed
US-11166891-B2 Bis phenyl hexa trien derivatives, preparation method thereof, and composition for skin whitening containing the same as an active ingredient KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2021-11-09 — — US disclosed
US-20200078279-A1 BIS PHENYL HEXA TRIEN DERIVATIVES, PREPARATION METHOD THEREOF, AND COMPOSITION FOR SKIN WHITENING CONTAINING THE SAME AS AN ACTIVE INGREDIENT KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KP) 2020-03-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11166891-B2 Bis phenyl hexa trien derivatives, preparation method thereof, and composition for skin whitening containing the same as an active ingredient TYR, MITF, TPH1 NFE2L2 33/4885CYP1A1 143/4885CYP1A2 395/4885
US-20200078279-A1 BIS PHENYL HEXA TRIEN DERIVATIVES, PREPARATION METHOD THEREOF, AND COMPOSITION FOR SKIN WHITENING CONTAINING THE SAME AS AN ACTIVE INGREDIENT TYR, MITF, TPH1 NFE2L2 33/4885CYP1A1 143/4885CYP1A2 395/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.